Puig J, Werner M, Dolz G, Pascagaza A, Daunis-I-Estadella P, Comas-Cufí M, González E, Fondevila J, Vega P, Murias E, Romero V, Martínez C, Aparici-Robles F, Morales-Caba L, Remollo S, Rodríguez-Caamaño I, Pérez-García C, Rosati S, Bashir S, Vielba-Gomez I, Aixut S, Paipa AJ, Martínez-Fernández J, Aguilar Y, Fandiño E, Barbieri G, García-Villalba B, Cuba V, Castaño M, Blasco J
Distal Access Catheter Improves Balloon Guide and Stent Retriever Thrombectomy Outcomes in Nonagenarians.
Brito-Zerón, P, Garcia, LTD, Flores-Chávez, A, Herranz-Pérez, JC, Hidalgo, PS, Sanchez-Berna, I, Gea, JP, Perez-Quintana, M, Robles, EM, Mascaró, O, Fonseca-Aizpuru, E, Guerrero, MB, Urbistondo, MM, Ramirez, M, Marcos, M, Escalante, B, Pasquau, F, Jiménez, I, Anducas, NV, Bonías, MA, Ramos-Casals, M, Montalvo, MA
A NOVEL AGE-DEFINED PHENOTYPIC LANDSCAPE IN MIXED CONNECTIVE TISSUE DISEASE: DISTINCT CLINICAL AND IMMUNOLOGICAL PATTERNS AT DIAGNOSIS IN 211 SPANISH PATIENTS
Mehra N, Antonarakis ES, Park SH, Goh JC, McDermott R, Sala Gonzalez N, Fong PC, Greil R, De Santis M, Yanez PE, Huang YH, Begbie SD, Rey F, Kramer G, Suzuki H, Saretsky TL, Ghate SR, Cui Y, Hosius C, Yu EY
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer.
Lapeña P, Urra X, Llopis J, Hernández-Meneses M, Cuervo G, Maisterra O, Escrihuela-Vidal F, Prats-Sánchez L, Sáez C, Olmos C, Hernández-Fernández F, Werner M, Pérez de la Ossa N, Quintana E, Moreno A, Chamorro A, Miró JM
Efficacy and safety of mechanical thrombectomy in acute ischaemic stroke secondary to infective endocarditis.
Rubio-Casadevall, J, Trallero, J, Calvo, C, Puigdemont, M, Carulla, M, Sanvisens, A, Ameijide, A, Vidal, A, Pla, C, Marruecos, J, Marcos-Gragera, R, Galceran, J
A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018
Doncel-Moriano Cubero A, Rodríguez-Vázquez A, Rosa I, Rudilosso S, Serrano M, Renú A, Cabero-Arnold A, Blasco J, Amaro S, Llull L, Molina CA, Cardona Portela P, Camps-Renom P, Millan M, Figueras-Aguirre G, Rodríguez-Campello A, Silva Y, Purroy F, Salvat M, Vargas M, Urra X, Chamorro Á
Trends in revascularization therapies for patients with acute stroke with large infarcts: a population-based study.
Domínguez-Armengol, G, Ribas-Aulinas, F, Balló, E, Alzamora-Sas, M, Serrat-Costa, M, Ruiz-Comellas, A, Forcadell-Peris, MJ, Toran, P, Martí-Lluch, R, Ponjoan, A, Blanch, J, Alves-Cabratosa, L, Zacarías-Pons, L, Tornabell-Noguera, E, Sánchez-Pérez, A, Berenguera-Ossó, A, Ramos, R
Health program for prEvention of cardiovascuLar disEases based on a risk screeNing strategy with Ankle-brachial index: HELENA study protocol
Medina, AC, Arostegui, IC, Garzo, A, Abril, L, Escoda, L, Cañamero, E, Cabezudo, E, Ortín, X, Biosca, C, Viñas, J, Bedoya, T, Giménez, A, Sarrà, J, Montes, YG, Balarí, AS, Oriol, A
Severe Infections in Newly Diagnosed Multiple Mieloma Patients Treated Frontline with Bortezomib, Lenalidomide and Dexamethasone (VRD) in Four Reference Centers
Lambea-Gil Á, Marti-Fabregas J, Cardona P, Rodriguez-Luna D, Millán M, Amaro S, Prats-Sanchez L, Silva Y, Seró L, Rodriguez-Campello A, Cánovas D, Martinez-Domeño A, Guasch-Jiménez M, Ezcurra-Díaz G, Carcel-Marquez J, Fernandez-Cadenas I, Pérez De La Ossa N, Abilleira S, Salvat-Plana M, Fagundez O, Camps-Renom P, Ramos-Pachón A
Effect of Onset-to-Admission Time and Care Bundle Achievement on Functional Outcomes in Patients With ICH: A Population-Based Study.
Trama, A, Bernasconi, A, Cañete, A, Carulla, M, Daubisse-Marliac, L, Rossi, S, De Angelis, R, Sanvisens, A, Katalinic, A, Paapsi, K, Went, P, Mousavi, M, Blum, M, Eberle, A, Lamy, S, Capocaccia, R, Didonè, F, Botta, L
Incidence and survival of rare adult solid cancers in Europe (EUROCARE-6): A population-based study
Garcia-Guiñon A, Charry PA, Jimenez M, Sarra J, Delgado I, Segura de la Torre L, Santaliestra M, Garcia-Pintos M, Gonzalez Y, Senin A, Motlló C, Abella E, Cabezudo E, Granell M, Sancho E, Herranz MJ, Seres Y, Gironella M, Soler JA, Marti-Tutusaus JM, Ben Azaiz R, Fernandez de Larrea C
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma.
Rodríguez-Antigüedad J, Martínez-Horta S, Puig-Davi A, Horta-Barba A, Pagonabarraga J, de Deus Fonticoba T, Jesús S, Cosgaya M, García Caldentey J, Ávila-Rivera MA, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Gómez Mayordomo V, González Ardura J, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Pareés I, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Ruíz Martínez J, Buongiorno MT, Ordás C, Valero C, Puente V, Kurtis M, Blázquez Estrada M, Martínez-Martín P, Mir P, Santos-García D, Kulisevsky J
Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline.
Xu Y, Yang JC, Zhao Y, Doucet L, Zhou J, Wang Y, Planchard D, Fan Y, Jin B, Han Z, Greillier L, Mazieres J, Sun M, Hu Y, Song X, Ding C, Wu L, Tang K, Liang L, Yao Y, Cheng Y, He Y, Ferreira BP, Ghiringhelli F, Felip E, Bosch-Barrera J, Liu A, Yu Y, Dong X, Gao J, Camidge DR, Nian W, Zhou C, Yang R, John T, Gao B, Bazhenova L, Nagasaka M, Wang J, Ren X, Xu F, Li W, Zhao D, Wang H, Sun S, Huang J, Zhu X, Zheng L, Jänne PA, Wang M
Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation.
